1623 Capital’s Cardlytics CDLX Stock Holding History

1623 Capital’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,258	Closed	-$306K	–	28
2022 Q3	$306K	Hold	3,258	–	–	0.19%	40
2022 Q2	$727K	Buy	3,258 +2,487	+323%	+$833K	0.45%	29
2022 Q1	$424K	Buy	+771	New	+$466K	0.21%	42
2021 Q4	–	Sell	-557	Closed	-$467K	–	61
2021 Q3	$467K	Hold	557	–	–	0.18%	53
2021 Q2	$706K	Buy	557 +172	+45%	+$194K	0.27%	40
2021 Q1	$422K	Buy	+385	New	+$508K	0.17%	39

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

GEH

General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

1623 Capital's CDLX Position: Q4 2022 in Review

1623 Capital sold out of Cardlytics (CDLX) in Q4 2022, closing a stake of 3,258 shares — an estimated $306K sold.

1623 Capital first reported a position in CDLX in Q1 2021 and held it in 6 quarters. The position peaked at $727K in Q2 2022. 121 funds tracked by Wall St. Rank hold CDLX as of Q4 2022.

1623 Capital reported no remaining Cardlytics position as of Q4 2022 after selling out during the quarter.
1623 Capital sold 3,258 Cardlytics shares in Q4 2022, an estimated $306K.
1623 Capital first reported a position in Cardlytics in Q1 2021 and held it in 6 quarters.
1623 Capital's Cardlytics position peaked at $727K in Q2 2022.
121 funds tracked by Wall St. Rank held Cardlytics as of Q4 2022.

Based on 1623 Capital's 13F filing for Q4 2022, filed 10 Feb 2023.